This Phase 2 clinical study will evaluate paridiprubart (EB05) in hospitalized patients with acute respiratory distress syndrome (ARDS) due to a variety of causes. This BARDA-funded project is ...

Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that has completed Phase III pivotal trials for the treatment of lung infections resulting from S. aureus ...

Meta-analysis of subjects from 4 randomized clinical trials supports the potential of enobosarm to optimize weight loss Start ...

Aridis Pharmaceuticals Inc (NASDAQ: ARDS) shares are gaining after announcing positive European Medicines Agency feedback on its proposed single confirmatory Phase 3 study of investigational ...

The collaboration outlines plans for multiple in vivo studies, designed to test opaganib as a potential medical countermeasure to treat phosgene i ...

TORONTO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing ...

This is the first randomized controlled trial investigating the efficacy and safety of low-dose prolonged methylprednisolone administration in early ARDS. This study tested a pathophysiologic ...

A spinoff company has been formed to produce a hormone supplement that reduces lung damage, but researchers still need to ...

What is the moon phase today? Today, Oct. 21, 2024, the moon is 19 days old and is in the Waning Gibbous phase of its lunar cycle. It is 78% illuminated. Moon phases reveal the passage of time in ...

AFTER a perfect record in this year’s championship, Ballygalget will be hoping that they can cap their season off in style ...

A Charlottesville startup is developing new drugs that target inflammation for people with acute lung injuries. It's received ...

FDA’s feedback supports the initiation of the Phase III trialAgitation-Aggression in Borderline Personality Disorder (BPD) acknowledged as a possible therapeutic indicationOryzon may use STAXI-2 Trait ...